The cause of type 1 diabetes remains unknown and is a central focus of Boston ... Identifying the presence of the peptide is a significant step, said Altindis, who collaborated on the project with C.

Of the two well-known rodent models of human type 1 diabetes (the non-obese diabetic ... genes and identification of cognate peptide(s) were predicted to follow. From there, identification of ...

This can help healthcare professionals determine whether someone has type 1 or type 2 diabetes. A C-peptide test can also determine whether the pancreas is making insulin. Physicians may also ...

Commentary: Social media users correctly spotted my misdiagnosis. Here are two diabetes tech wearables everyone should know ...

Diabetes is a very complicated condition and there are many different types, but type 2 diabetes ... safety of new peptide hormone drugs. We have also demonstrated that our novel drugs can lead to ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The results support the robustness of the treatment effects and underscore the potential for precision medicine to slow and delay disease progression in Type 1 Diabetes. Summary of the detailed ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...